Steward Partners Investment Advisory’s Ironwood Pharmaceuticals IRWD Stock Holding History

Steward Partners Investment Advisory’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72	Hold	17	–	–	﹤0.01%	4573
2026 Q1	$60	Hold	17	–	–	﹤0.01%	4357
2025 Q4	$57	Hold	17	–	–	﹤0.01%	4245
2025 Q3	$22	Hold	17	–	–	﹤0.01%	4228
2025 Q2	$12	Hold	17	–	–	﹤0.01%	4097
2025 Q1	$25	Buy	+17	New	+$40	﹤0.01%	3985
2020 Q1	–	Sell	-2	Closed	–	–	2600
2019 Q4	$0	Sell	2 -1	-33%	-$11	﹤0.01%	2663
2019 Q3	$0	Sell	3 -250	-99%	-$2.43K	﹤0.01%	2687
2019 Q2	$2K	Buy	+253	New	+$2.83K	﹤0.01%	2436
2018 Q4	–	Sell	-299	Closed	-$5K	–	1444
2018 Q3	$5K	Hold	299	–	–	﹤0.01%	2121
2018 Q2	$5K	Hold	299	–	–	﹤0.01%	1990
2018 Q1	$3K	Hold	299	–	–	﹤0.01%	1920
2017 Q4	$3K	Hold	299	–	–	﹤0.01%	1631
2017 Q3	$3K	Buy	+299	New	+$4.12K	﹤0.01%	1406

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Steward Partners Investment Advisory's IRWD Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 17 shares worth $72. The position accounts for ﹤0.01% of the portfolio, ranked #4573.

Steward Partners Investment Advisory first reported a position in IRWD in Q3 2017 and has held it in 14 quarters since. The position peaked at $5K in Q3 2018. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Steward Partners Investment Advisory held 17 shares of Ironwood Pharmaceuticals worth $72 as of Q2 2026.
Steward Partners Investment Advisory left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4573 holding.
Steward Partners Investment Advisory first reported a position in Ironwood Pharmaceuticals in Q3 2017 and has held it in 14 quarters since.
Steward Partners Investment Advisory's Ironwood Pharmaceuticals position peaked at $5K in Q3 2018.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.